November 12, 2015 @ 10:00 am – 11:00 am America/Chicago Timezone
Tammy McNeil, Great Plains QIN
402/476-1399 x504


Start WebEx Playback


Presentation handout


Vaccination rates for children have steadily risen well over 90 percent the past few years, but the rates for older adults getting flu, pneumonia, tetanus or shingles shots – the four most used vaccines among the elderly – have stayed stubbornly flat and trail national goals, according to the latest federal data. That leaves millions of older adults at risk of dying, being hospitalized, or, in the case of shingles, suffering debilitating effects that can last years. With the fall flu vaccination season starting this month, public health officials say they are disappointed by the trends¹.

Dr. Tan, Chief Strategy Officer for the Immunization Action Coalition, offers insight as to the immunization rates in our country, the reasons why rates are lower than desired and what we can to do raise awareness and increase rates of immunizations for our adult population.


Target Audience

All healthcare professionals and community partners interested in improving immunization rates were invited to attend.



Upon completion of this session, participants will have a better understanding of:

  1. Current adult immunization rates
  2. Potential reasons why immunization rates are lower than desired
  3. The importance of adult immunizations
  4. Strategies to improve overall immunization rates for our patient population



LJ Tan PhotoL.J. Tan, MS, PhD, Chief Strategy Officer, Immunization Action Coalition (IAC)

L.J. Tan is the Chief Strategy Officer for the Immunization Action Coalition, which he joined January 1st, 2013. Prior to that, L.J was the Director of Medicine and Public Health at the American Medical Association (AMA) for 15 years.

Dr. Tan also serves as Co-Chair of the National Adult and Influenza Immunization Summit, together with the CDC and the NVPO.

Dr. Tan recently served on the National Quality Forum’s Adult Immunizations Expert Committee, and currently serves on the Pharmacy Quality Alliance’s Adult Immunization Working Group, on the European Society of Clinical Microbiology and Infectious Diseases Vaccine Study Group (EVASG), and as an editor for the Journal for Disaster Medicine and Public Health Preparedness, BMC Infectious Diseases and for Medscape Infectious Diseases.

He just completed his term as an elected member of the federal National Vaccine Advisory Committee (NVAC). He still serves on the NVAC’s HPV and Vaccine Confidence working groups. Previously, L.J chaired the Immunization Infrastructure WG and also served on the vaccine safety WG.

Dr. Tan also served as a liaison member of the federal Advisory Committee for Immunization Practices (ACIP) for 12 years, and he still serves on the Adult Immunization working group. Previously, L.J. also served on the influenza, zoster and evidence-based working groups.

  1. Source: Kaiser Health News; September 15, 2015. Author: Phil Galewitz

This event was brought to you by the Great Plains Quality Innovation Network